Skip to main content
. 2011 Jun;6(6):1301–1307. doi: 10.2215/CJN.08630910

Table 4.

Renal outcome at the last observation

Combination Therapy (n = 40) Heparin-Warfarin and Dipyridamole Therapy (n = 34)
No proteinuria (uP/Cr <0.2 g/g) 24 (60.0%) 18 (52.9%)
Mild proteinuria (≤0.2 uP/Cr <1.0 g/g) 12 (30.0%) 6 (17.6%)
Heavy proteinuria (uP/Cr ≥1.0 g/g) 1 (2.5%) 4 (11.8%)
Renal insufficiency (eGFR <60 ml/min per 1.73 m2) 1 (2.5%) 1 (2.9%)
ESRF (requiring renal replacement therapy) 2 (5.0%) 5 (14.7%)